These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28445936)

  • 1. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
    Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
    Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
    Chen M; Li J; Zhuang C; Cai Z
    Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
    Tuo Z; Zhang J; Xue W
    Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma.
    Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L
    Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
    Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
    Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504.
    Chen Q; Fu L
    PLoS One; 2020; 15(1):e0227568. PubMed ID: 31929567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression.
    Gong H; Wen H; Zhu X; Lian Y; Yang X; Qian Z; Zhu J
    Tumour Biol; 2017 Jun; 39(6):1010428317705336. PubMed ID: 28618933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316.
    Wang F; Zu Y; Huang W; Chen H; Xie H; Yang Y
    Biochem Biophys Res Commun; 2018 Sep; 504(1):171-176. PubMed ID: 30177388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
    Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis.
    Liu XJ; Li SL; Li JS; Lu H; Yin LL; Zheng WF; Wang WC
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2624-2630. PubMed ID: 29771411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
    Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
    Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.
    Jiang X; Li J; Wang W; Hu Z; Guan C; Zhao Y; Li W; Cui Y
    Aging (Albany NY); 2020 Jan; 12(2):1237-1255. PubMed ID: 31978895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer.
    Li J; Zhuang C; Liu Y; Chen M; Chen Y; Chen Z; He A; Lin J; Zhan Y; Liu L; Xu W; Zhao G; Guo Y; Wu H; Cai Z; Huang W
    J Exp Clin Cancer Res; 2016 Jun; 35(1):99. PubMed ID: 27328915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZFAS1 functions as an oncogenic long non-coding RNA in bladder cancer.
    Yang H; Li G; Cheng B; Jiang R
    Biosci Rep; 2018 May; 38(3):. PubMed ID: 29678899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577.
    Wei N; Wei H; Zhang H
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3085-3093. PubMed ID: 29863254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CRNDE promotes the progression of bladder cancer.
    Cheng J; Chen J; Zhang X; Mei H; Wang F; Cai Z
    Biomed Pharmacother; 2018 Mar; 99():638-644. PubMed ID: 29710461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
    J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.